HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment - Wikidata - wikimedia - TriplyDB

HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment

HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment

http://www.wikidata.org/entity/Q34140484

about

Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines Re-evaluation of PD-1 expression by T cells as a marker for immune exhaustion during SIV infection Developments in HIV-1 immunotherapy and therapeutic vaccination.The immunology of Leishmania/HIV co-infection.Loss and dysregulation of Th17 cells during HIV infection.Defective IL-17- and IL-22-dependent mucosal host response to Candida albicans determines susceptibility to oral candidiasis in mice expressing the HIV-1 transgene.Immunogenetics of small ruminant lentiviral infections Incomplete normalization of regulatory t-cell frequency in the gut mucosa of Colombian HIV-infected patients receiving long-term antiretroviral treatment.A comparison of seminal hepatitis C virus (HCV) RNA levels during recent and chronic HCV infection in HIV-infected and HIV-uninfected individuals Site-specific differences in T cell frequencies and phenotypes in the blood and gut of HIV-uninfected and ART-treated HIV+ adults.High Expression of Antiviral Proteins in Mucosa from Individuals Exhibiting Resistance to Human Immunodeficiency Virus Higher Frequency of NK and CD4+ T-Cells in Mucosa and Potent Cytotoxic Response in HIV Controllers.Nef promotes evasion of human immunodeficiency virus type 1-infected cells from the CTLA-4-mediated inhibition of T-cell activation.HIV-specific CD8⁺ T cells and HIV eradication CD4+FOXP3+ Regulatory T-Cell Subsets in Human Immunodeficiency Virus Infection.Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study.Tim-3 inhibits macrophage control of Listeria monocytogenes by inhibiting Nrf2.Regulatory T cells in HIV infection: can immunotherapy regulate the regulator?PD-1 coinhibitory signals: the link between pathogenesis and protection.Review article: the intersection of mucosal pathophysiology in HIV and inflammatory bowel disease, and its implications for therapy.Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.HIV Persistence in Gut-Associated Lymphoid Tissues: Pharmacological Challenges and Opportunities.Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS.[Key role played by the gut associated lymphoid tissue during human immunodeficiency virus infection].Preferential loss of gut-homing α4β7 CD4+ T cells and their circulating functional subsets in acute HIV-1 infection.Chronically HIV-1 Infected Patients Exhibit Low Frequencies of CD25+ Regulatory T Cells.Longitudinal analysis of distribution and function of plasmacytoid dendritic cells in peripheral blood and gut mucosa of HIV infected patients.In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock" Strategy for HIV-1 Treatment.Helios + Regulatory T cell frequencies are correlated with control of viral replication and recovery of absolute CD4 T cells counts in early HIV-1 infection.HIV evolution and diversity in ART-treated patients.Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection.

P2860

Q26827712-05BD9C3A-183C-49BD-B493-C627BA4D365C Q27331338-AF26F114-D1FC-4F42-A0C5-BC5C65C17DF4 Q30364312-41001C02-3B0C-407C-994B-E5E6923E803A Q30428365-05D73B0D-E71E-4E37-A478-CE47333EBB0B Q34350569-B151D3DD-B8CD-4761-9F1C-F440E3514495 Q34423476-F6DB7F25-45D4-493E-9D1F-2C58547B7CCD Q34434913-F00AFB2C-5FF6-4BBD-B364-341842229341 Q34963393-72CA7092-B9D3-4C33-8688-AF593484344C Q35102600-D5FEB7C4-C3DE-449C-82AA-2FA45BCFEAEA Q35587218-BEFB688B-4C84-4965-B031-18BC2FE2133C Q35668959-0DF39B03-4E9C-4F78-B2B7-C88A4F3DB0CB Q35751335-FE4B3C82-82C0-4624-8215-037712506006 Q36255107-1D8B10EC-8730-4EC0-9A31-9CD4B4F7EAD1 Q36515071-70C39E51-D7E9-4E34-B134-D478A6CB6D16 Q37054806-D751B99E-989B-4668-9608-DFDF85D23FBD Q37130166-9753CEE1-FF72-4C54-A65E-53F3872BACAC Q37644227-682C04A5-0793-4CF1-9CFD-D57CE9552C8A Q38068406-66D6DB5E-114A-450E-806F-999952039C40 Q38095246-203B278E-759F-475A-8307-C2A970B18CE5 Q38255412-6D9F6A68-9525-4394-A5BA-297DC30E8F63 Q40222958-4B152EBF-23EF-46C0-8D8E-89F1E7247EAB Q40256176-2935D840-A869-4DCD-B635-EE92C2BA7C71 Q40847649-FEE84138-B52C-4ED0-97DA-21FECDBAABC2 Q40869409-7D2BC1F0-9124-4557-91D0-A8B642A64D80 Q41049887-6A14D6C3-DEA4-4C25-B1FC-3D31E5313ABC Q42157400-7A771CE4-6372-4875-8AFD-C4DD24EB801C Q42254144-4D2C1FB9-B83F-48D4-843E-B1BF19348B22 Q42381408-91A9727A-58CF-4026-8643-441210C77BE8 Q47139254-6674E7C8-1C33-4FAB-B70F-B1D98F394ABE Q47548221-9329FC6B-E07B-44A9-842F-2BF2D23D3E1C Q54259809-8E4D95F4-6AE8-44A4-825F-0D0D2A533189

P2860

HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment

http://www.wikidata.org/entity/Q34140484

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

HIV-induced T-cell activation/ ...... ly by antiretroviral treatment

@ast

HIV-induced T-cell activation/ ...... ly by antiretroviral treatment

@en

HIV-induced T-cell activation/ ...... ly by antiretroviral treatment

@nl

type

label

HIV-induced T-cell activation/ ...... ly by antiretroviral treatment

@ast

HIV-induced T-cell activation/ ...... ly by antiretroviral treatment

@en

HIV-induced T-cell activation/ ...... ly by antiretroviral treatment

@nl

prefLabel

HIV-induced T-cell activation/ ...... ly by antiretroviral treatment

@ast

HIV-induced T-cell activation/ ...... ly by antiretroviral treatment

@en

HIV-induced T-cell activation/ ...... ly by antiretroviral treatment

@nl

P1433

Q34140484-0FAB3A81-A775-4B79-A94D-0162EA217E3A

P1476

Q34140484-2D7A469F-BB94-41BE-A446-A9B69EF57040

P2093

Q34140484-8DB3E0AD-A7E2-4D72-BE2E-8C990A353CC7

Q34140484-A7006A04-2D3F-431C-8971-9D3754996D74

Q34140484-BA7FE4A9-4E93-48EF-8A33-1458E7851CF8

Q34140484-F65F864B-286C-4C68-8B34-C9B27A86270E

P2860

Q34140484-03D0F769-1733-419A-A5FD-C88C3B107EB1

Q34140484-0D3A982B-A21A-4E33-BE16-E1C77EE340DF

Q34140484-0E56E54B-C003-488F-AA64-3BFFB62B507C

Q34140484-22538A5C-A827-47CA-887C-5083BE1471CB

Q34140484-25E234A7-E899-46F9-9243-75AEC9940167

Q34140484-2FEC0422-890D-47B0-872B-57849B63B3ED

Q34140484-37AA7354-038B-4555-86B9-3AD46BAC99F6

Q34140484-38B7F8AA-3458-42BD-B820-4E98B4D90CC6

Q34140484-39E8CFA5-DFFF-467D-A5B4-3375E6111802

Q34140484-3C6FA08D-F96A-4A26-A506-49380E5AACC5

P304

Q34140484-EBABDAA0-03E4-4E33-8EF6-77AAEBD4BF00

P31

Q34140484-05AA3545-85DA-473A-9C55-77848130E24A

P356

Q34140484-3C602BE9-4256-43CE-8F31-8292EB866186

P407

Q34140484-A97AB0C4-BB43-4630-81C3-356DB5A48C68

P433

Q34140484-17A1C7AC-04B9-4E54-A84F-59313A38492E

P478

Q34140484-BC399DF8-C16C-4016-9123-EE37D12ECE9C

P50

Q34140484-3E083AC9-60C2-4964-BDE6-8B6AF5BCE8FF

P577

Q34140484-115C2019-AC34-4686-B361-91665AA3CEA8

P5875

Q34140484-A7957CB9-7FC7-4CBD-9EBF-CEE2A8B1C351

P698

Q34140484-731786BC-5EC2-44CD-B438-C9B3886F55DF

P921

Q34140484-E1CCB1CC-763B-42E8-8879-F7F6580E7688

P932

Q34140484-291B3528-28B8-496F-A9E1-023301B29135

P356

JOURNAL.PONE.0030307

P1433

P1476

HIV-induced T-cell activation/ ...... ly by antiretroviral treatment

@en

P2093

Carlos Julio Montoya

http://www.w3.org/2001/XMLSchema#string

Cesar Mauricio Rueda

http://www.w3.org/2001/XMLSchema#string

Claire A Chougnet

http://www.w3.org/2001/XMLSchema#string

Maria Teresa Rugeles

http://www.w3.org/2001/XMLSchema#string

P2860

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

Th17 and regulatory T cells in mediating and restraining inflammation.

PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2

Restoring function in exhausted CD8 T cells during chronic viral infection

HIV pathogenesis: 25 years of progress and persistent challenges

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease

PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status.

P304

e30307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0030307

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Paula A Velilla

P577

2012-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221776376

http://www.w3.org/2001/XMLSchema#string

P698

22276176

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3261885

http://www.w3.org/2001/XMLSchema#string